Peñas-Herrero Irene, de la Serna-Higuera Carlos, Perez-Miranda Manuel
Department of Gastroenterology and Hepatology, Hospital Universitario Rio Hortega, Dulzaina 2, 47012, Valladolid, Spain.
J Hepatobiliary Pancreat Sci. 2015 Jan;22(1):35-43. doi: 10.1002/jhbp.182. Epub 2014 Nov 13.
Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) has been introduced as an alternative to percutaneous transhepatic gallbladder drainage for the treatment of acute cholecystitis in non-surgical candidates. A systematic review of the English language literature through PubMed search until June 2014 was conducted. One hundred and fifty-five patients with acute cholecystitis treated with EUS-GBD in eight studies and 12 case reports, and two patients with EUS-GBD for other causes were identified. Overall, technical success was obtained in 153 patients (97.45%) and clinical success in 150 (99.34%) patients with acute cholecystitis. Adverse events developed in less than 8% of patients, all of them managed conservatively. EUS-GBD has been performed with plastic stents, nasobiliary drainage tubes, standard or modified tubular self-expandable metal stents (SEMS) and lumen-apposing metal stents (LAMS) by different authors with apparently similar outcomes. No comparison studies between stent types for EUS-GBD have been reported. EUS-GBD is a promising novel alternative intervention for the treatment of acute cholecystitis in high surgical risk patients. Feasibility, safety and efficacy in published studies from expert centers are very high compared to currently available alternatives. Further studies are needed to establish the safety and long-term outcomes of this procedure in other practice settings before EUS-GBD can be widely disseminated.
内镜超声引导下胆囊引流术(EUS-GBD)已被引入,作为经皮经肝胆囊引流术的替代方法,用于治疗非手术候选患者的急性胆囊炎。通过PubMed搜索对截至2014年6月的英文文献进行了系统评价。在八项研究和12篇病例报告中,共确定了155例接受EUS-GBD治疗的急性胆囊炎患者,以及2例因其他原因接受EUS-GBD治疗的患者。总体而言,153例急性胆囊炎患者(97.45%)获得技术成功,150例(99.34%)获得临床成功。不到8%的患者发生不良事件,所有这些不良事件均通过保守治疗处理。不同作者使用塑料支架、鼻胆管引流管、标准或改良管状自膨式金属支架(SEMS)和管腔贴壁金属支架(LAMS)进行了EUS-GBD,结果明显相似。尚未有关于EUS-GBD支架类型之间比较研究的报道。EUS-GBD是一种有前景的新型替代干预措施,用于治疗高手术风险患者的急性胆囊炎。与目前可用的替代方法相比,专家中心发表的研究中其可行性、安全性和有效性非常高。在EUS-GBD能够广泛推广之前,需要进一步研究以确定该手术在其他实际应用环境中的安全性和长期疗效。